docLamoka (NY 139)
download 
Report Transcription
LAMOKA Pedigree: The cross was made in 1998. The female was NY120 and the male was NY115. Grandparents are Kanona, AF186-2, Pike and NY88. Lamoka was first evaluated as Y28-9, then as NY139. Lamoka is named after one of a pair of twin lakes in upstate New York. Market Features: Lamoka is a chipping variety that produces attractive, round tubers with slightly to moderately textured skin. Tubers exhibit few external defects, but have shown internal necrosis in a few trials. Small areas of translucent tissue have also been observed inside tubers in a few trials. Specific gravity has averaged about 0.004 less than Atlantic in 33 trials. Chip color out of cold storage has been excellent, comparable to or better than Snowden in most trials. Production Features: Late season maturity. Full season yield is good, averaging 93% of Atlantic in 34 upstate NY trials. Eight to nine inch spacing and 150 pounds of nitrogen/acre are recommended. Tuber size is similar to Atlantic. Tuber dormancy is about one week longer than Atlantic. White-tipped magenta flowers are distinctive, vines set many fruit. Reaction to Diseases: Good resistance to common scab. Resistant to golden nematode race Ro1. Developed with support from New York State Department of Agriculture & Markets, USDA/ARS, USDA/APHIS, USDA/NIFA, New York and Pennsylvania Potato Growers. Evaluation assisted by NE1031. An application has been filed for PVP.
Similar documents
Diabetic Gastroparesis Global Clinical Trials Review: Latest Report Available on Market Reports World
Gastroparesis is a condition in which your stomach cannot empty itself of food in a normal fashion. It can be caused by damage to the vagus nerve, which regulates the digestive system. This report provides elemental information and data relating to the clinical trials on Gastroparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
Fatty Liver Disease Global Clinical Trials Review Industry Key Trends, Size, Growth, Shares and Forecast Research Report
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease that has been shown to progress to cirrhosis and hepatocellular carcinoma. This article reviews the prevalence of NAFLD and the factors associated this disorder, and with the more advanced stages of NAFLD.
New report shares details about the Cholestasis global clinical trials conducted in 2016
Cholestasis Global Clinical Trials Report provides elemental information and data relating to the clinical trials on Cholestasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
Cholecystitis Global Clinical Trials- Market Analysis, Trends, Regulations and Competitive Landscape 2016
Cholecystitis Clinical report provides top line data relating to the clinical trials on Cholecystitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.
Latest Report of Appendicitis Global Clinical - Classification, Prevention, Treatment and Symptoms
The report, “Appendicitis Global Clinical Trials Review, H1, 2016" provides an overview of Appendicitis clinical trials scenario. This report provides top line data relating to the clinical trials on Appendicitis. Report includes an overview of trial numbers and their average enrolment in top countries conducted across the globe.
